Latest News
Via MarketBeat · February 24, 2026
Blue Hat announced the pricing of its public offering of 32 million units last week, at a price of $0.2 per unit.
Via Stocktwits · February 24, 2026
The Motley Fool recently surveyed 2,000 individual investors to gauge their optimism about the stock market and their concerns.
Via The Motley Fool · February 24, 2026
WBD also noted that the merger agreement with Netflix remains in effect, adding that the WBD board continues to recommend it over the Paramount offer.
Via Stocktwits · February 24, 2026
Shoals Technologies Group (NASDAQ:SHLS) Reports Q4 Revenue Beat Amid Significant Margin Pressurechartmill.com
Via Chartmill · February 24, 2026
The two companies will work together to integrate advanced AI capabilities into Intuit’s suite of financial and business tools, creating solutions that simplify workflows.
Via Stocktwits · February 24, 2026
First Watch Restaurant Group (NASDAQ:FWRG) Reports Mixed Q4 Earnings, CFO Retirement, and Cautious 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
Keurig Dr Pepper (NASDAQ:KDP) Beats Q4 2025 Estimates and Provides Bullish 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
Constellation Energy (NASDAQ:CEG) Reports Mixed Q4 2025 Results with Revenue Beat and Strategic Growth Focuschartmill.com
Via Chartmill · February 24, 2026
Avanos Medical Inc (NYSE:AVNS) Stock Plummets 13% Despite Q4 Earnings Beatchartmill.com
Via Chartmill · February 24, 2026
Stride Inc. (NYSE:LRN) Presents a Compelling Case as a Quality Business at a Discounted Valuationchartmill.com
Via Chartmill · February 24, 2026
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) Reports Q4 Revenue Beat and Strong Clinical Progresschartmill.com
Via Chartmill · February 24, 2026
Leonardo DRS Inc (NASDAQ:DRS) Surpasses Q4 2025 Estimates and Provides Strong 2026 Guidancechartmill.com
Via Chartmill · February 24, 2026
Option Care Health Inc (NASDAQ:OPCH) Reports Mixed Q4 2025 Results and Cautious 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
Orthofix Medical Inc (NASDAQ:OFIX) Posts Strong Q4 Profit Beat Despite Revenue Miss, Provides 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
Which stocks are moving before the opening bell on Tuesday?chartmill.com
Via Chartmill · February 24, 2026
S&P 500 nuclear giant Constellation Energy is down nearly 17% in 2026 but has rallied since bottoming on Feb. 5.
Via Investor's Business Daily · February 24, 2026
Fulcrum Therapeutics (NASDAQ:FULC) Q4 2025 Earnings: Pociredir Data Steals Spotlight Amid In-Line Financialschartmill.com
Via Chartmill · February 24, 2026
CrowdStrike Holdings Inc. (CRWD) released its 2026 Global Threat Report on Tuesday, painting an alarming picture of an adversary landscape supercharged by artificial intelligence.
Via Benzinga · February 24, 2026
Arvinas Inc (NASDAQ:ARVN) Stock Plummets After Q4 2025 Earnings and Revenue Miss Estimateschartmill.com
Via Chartmill · February 24, 2026
Repligen Corp (NASDAQ:RGEN) Stock Falls Despite Q4 Earnings Beat as 2026 Guidance Disappointschartmill.com
Via Chartmill · February 24, 2026
Havertys Furniture (NYSE:HVT) Beats Q4 Earnings and Revenue Estimates, Stock Surgeschartmill.com
Via Chartmill · February 24, 2026
DigitalOcean Holdings Inc (NYSE:DOCN) Beats Q4 Estimates and Raises Outlook Despite Share Dipchartmill.com
Via Chartmill · February 24, 2026
NRG Energy Inc (NYSE:NRG) Reports Strong Q4 2025 Earnings Beat and Reaffirms 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
Via Benzinga · February 24, 2026
Kyntra Bio announces positive data for FG-3246 plus enzalutamide in metastatic castration-resistant prostate cancer.
Via Benzinga · February 24, 2026
Amazon invests $12 billion in data centers in Louisiana, Merck & Co., Inc. receives positive coverage, and Horizon Kinetics Inflation Beneficiaries ETF shows slight growth.
Via Benzinga · February 24, 2026
Axogen Inc (NASDAQ:AXGN) Reports Q4 2025 Revenue Growth but Misses Profit Estimateschartmill.com
Via Chartmill · February 24, 2026
Bowhead Specialty Holdings Inc. (NYSE:BOW) Reports Q4 2025 Revenue Beat and Full-Year Growthchartmill.com
Via Chartmill · February 24, 2026
Centrus Energy is America's premier uranium enricher, but there are some nuances to this story.
Via The Motley Fool · February 24, 2026
Fidelity National Info Serv (NYSE:FIS) Q4 2025 Earnings: Strategic Pivot Fuels Strong 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
AdaptHealth Corp. (NASDAQ:AHCO) Reports Mixed Q4 2025 Results but Provides Strong 2026 Guidancechartmill.com
Via Chartmill · February 24, 2026
Albany International Corp. (NYSE:AIN) Posts Mixed Q4 2025 Results with Revenue Beat and Strategic Portfolio Shiftchartmill.com
Via Chartmill · February 24, 2026
Via Benzinga · February 24, 2026
Etsy's Momentum slides to 19.26 as negative trends persist. Skepticism rises after the $1.2B Depop sale and mixed Q4 results.
Via Benzinga · February 24, 2026
Enviri Corp (NYSE:NVRI) Reports Mixed Q4 2025 Results, Beats Earnings Estimates but Misses on Revenuechartmill.com
Via Chartmill · February 24, 2026
Xometry Inc. (NASDAQ:XMTR) Surges on Strong Q4 Earnings Beat and Robust 2026 Outlookchartmill.com
Via Chartmill · February 24, 2026
Apellis Pharmaceuticals Inc (NASDAQ:APLS) Reports Q4 2025 Earnings Beat Amid Mixed Revenue Resultschartmill.com
Via Chartmill · February 24, 2026
Via Benzinga · February 24, 2026
American Tower Corp. (NYSE:AMT) Q4 2025 Earnings: AFFO Per Share Crushes Estimates, 2026 Revenue Outlook Cautiouschartmill.com
Via Chartmill · February 24, 2026
Via Talk Markets · February 24, 2026
Harmony Biosciences Holdings (NASDAQ:HRMY) Reports Q4 2025 Revenue In Line, Earnings Miss Amid Pipeline Investmentchartmill.com
Via Chartmill · February 24, 2026
U.S. Customs and Border Protection decided to impose a 10% tariff under Section 122 on all non-exempt goods, effective from 12.01 am Tuesday, instead of the 15% tariff he indicated on Saturday.
Via Benzinga · February 24, 2026
Credit cards aren't always the right move. Here are three situations where using your debit card (or cash) is the smarter financial choice.
Via The Motley Fool · February 24, 2026
AbbVie's dividend yield is far above the market's, and the dividend has been growing for years.
Via The Motley Fool · February 24, 2026
Lowe's (LOW) will release Q4 earnings on Feb. 25. Analysts expect $1.94 EPS and $20.34B revenue. Dividend yield is 1.75%. $6,000 annually needs 1,250 shares.
Via Benzinga · February 24, 2026